ZA988788B - Sulfonamide-substituted chromans processes for their preparation their use as a medicament and pharmaceutical preparations comprising them - Google Patents

Sulfonamide-substituted chromans processes for their preparation their use as a medicament and pharmaceutical preparations comprising them

Info

Publication number
ZA988788B
ZA988788B ZA988788A ZA988788A ZA988788B ZA 988788 B ZA988788 B ZA 988788B ZA 988788 A ZA988788 A ZA 988788A ZA 988788 A ZA988788 A ZA 988788A ZA 988788 B ZA988788 B ZA 988788B
Authority
ZA
South Africa
Prior art keywords
sulfonamide
medicament
processes
preparation
pharmaceutical preparations
Prior art date
Application number
ZA988788A
Other languages
English (en)
Inventor
Joachim Brendel
Uwe Gerlach
Hans Jochen Lang
Klaus Weidmann
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of ZA988788B publication Critical patent/ZA988788B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
ZA988788A 1997-09-26 1998-09-25 Sulfonamide-substituted chromans processes for their preparation their use as a medicament and pharmaceutical preparations comprising them ZA988788B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742508A DE19742508A1 (de) 1997-09-26 1997-09-26 Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
ZA988788B true ZA988788B (en) 1999-03-26

Family

ID=7843708

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA988788A ZA988788B (en) 1997-09-26 1998-09-25 Sulfonamide-substituted chromans processes for their preparation their use as a medicament and pharmaceutical preparations comprising them

Country Status (25)

Country Link
US (1) US6177449B1 (tr)
EP (1) EP0906911B1 (tr)
JP (1) JP4422222B2 (tr)
KR (1) KR19990030120A (tr)
CN (1) CN1216763A (tr)
AR (1) AR014915A1 (tr)
AT (1) ATE265445T1 (tr)
AU (1) AU755735B2 (tr)
BR (1) BR9803367A (tr)
CA (1) CA2248300C (tr)
CZ (1) CZ307198A3 (tr)
DE (2) DE19742508A1 (tr)
ES (1) ES2221107T3 (tr)
HR (1) HRP980528A2 (tr)
HU (1) HUP9802155A3 (tr)
ID (1) ID20967A (tr)
IL (1) IL126280A (tr)
NO (1) NO984476L (tr)
NZ (1) NZ332030A (tr)
PL (1) PL328854A1 (tr)
RU (1) RU2220965C2 (tr)
SK (1) SK131898A3 (tr)
TR (1) TR199801903A2 (tr)
TW (1) TW565559B (tr)
ZA (1) ZA988788B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19748469A1 (de) * 1997-11-03 1999-05-06 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE19858253A1 (de) * 1998-12-17 2000-06-21 Aventis Pharma Gmbh Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
FI20011507A0 (fi) * 2001-07-10 2001-07-10 Orion Corp Uusia yhdisteitä
US7001660B2 (en) * 2001-07-16 2006-02-21 Gilbert Garitano Images in solids surfaces
FI20030030A0 (fi) * 2003-01-09 2003-01-09 Orion Corp Uusia yhdisteitä
US7368582B2 (en) 2003-10-17 2008-05-06 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
EP1871758B1 (en) * 2005-04-12 2010-08-25 Abbott Products GmbH Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers
US7714150B2 (en) 2005-04-12 2010-05-11 Solvay Pharmaceuticals Gmbh Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
TW201022223A (en) * 2008-08-14 2010-06-16 Nissan Chemical Ind Ltd Di-substituted benzopyrane compound

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820834A (en) 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
FR2639349B1 (fr) 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
US5428031A (en) 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
AU711986B2 (en) * 1996-05-15 1999-10-28 Hoechst Aktiengesellschaft Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
DE19706675A1 (de) * 1997-02-20 1998-08-27 Hoechst Ag Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19742509A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
TR199801903A3 (tr) 1999-04-21
KR19990030120A (ko) 1999-04-26
ID20967A (id) 1999-04-01
CA2248300A1 (en) 1999-03-26
JPH11158171A (ja) 1999-06-15
RU2220965C2 (ru) 2004-01-10
HUP9802155A2 (hu) 1999-09-28
AU755735B2 (en) 2002-12-19
US6177449B1 (en) 2001-01-23
BR9803367A (pt) 2000-05-09
TR199801903A2 (tr) 1999-04-21
TW565559B (en) 2003-12-11
AU8708298A (en) 1999-04-15
EP0906911A1 (de) 1999-04-07
SK131898A3 (en) 1999-06-11
CA2248300C (en) 2008-12-02
DE59811267D1 (de) 2004-06-03
NZ332030A (en) 2000-04-28
HUP9802155A3 (en) 2002-04-29
NO984476D0 (no) 1998-09-25
CN1216763A (zh) 1999-05-19
NO984476L (no) 1999-03-29
HU9802155D0 (en) 1998-11-30
DE19742508A1 (de) 1999-04-01
ATE265445T1 (de) 2004-05-15
HRP980528A2 (en) 1999-06-30
AR014915A1 (es) 2001-04-11
PL328854A1 (en) 1999-03-29
CZ307198A3 (cs) 1999-04-14
IL126280A0 (en) 1999-05-09
EP0906911B1 (de) 2004-04-28
IL126280A (en) 2003-10-31
ES2221107T3 (es) 2004-12-16
JP4422222B2 (ja) 2010-02-24

Similar Documents

Publication Publication Date Title
IL120827A0 (en) Sulfonamide-substituted chromans processes for their preparation their use as a medicament or diagnostic and medicament comprising them
HUP0002517A3 (en) Derivatives of acyl-piperazinil-pyrimidins, preparation thereof, pharmaceutical compositions containing them and their use as medicaments
IL127132A (en) Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
HK1019606A1 (en) Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
IL126280A0 (en) Sulfonamide-substituted chromans processes for their preparation their use as a medicament and pharmaceutical preparations comprising them
HUP9903353A3 (en) 7alpha-(methyl-amino-pentyl)-estratrienes, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl) -estratrienes and use thereof for production of drugs
IL123360A0 (en) Sulfonamide-substituted chromans processes for their preparation their use as a medicament or diagnostic aid and medicaments comprising them
HK1050673A1 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
ZA989982B (en) Sulfonamide-substituted benzopyran derivatives processes for their preparation their use as a medicament and pharmaceutical preparations comprising them
ZA986877B (en) Pharmaceutical formulation for camptothecin analogues in gelatin capsule
ZA988790B (en) Sulfonamide-substituted chromans processes for their preparation their use as a medicament or diagnostic and pharmaceutical preparations comprising them
IL126955A0 (en) Sulfonamide-substituted fused 5-membered ring compounds their use as a medicament and pharmaceutical preparations comprising them
IL123454A0 (en) Sulfonamide-substituted fused 7-membered ring compounds their use as a medicament and pharmaceutical preparations comprising them
IL125642A0 (en) Sulfonamide-substituted compounds processes for their preparation their use as a medicament or diagnostic and medicaments comprising them
HK1047037B (zh) 含聚殼糖的蘭諾索爾(毫微溶膠)藥物製劑及其製備
IL127690A0 (en) Pyridinocyclohexano-1,3- pyrimidine derivatives their preparation their use as medicaments and pharmaceutical formulations including them
IL123229A0 (en) Sulfonamide-substituted compounds process for their preparation their use as a medicament or diagnostic and medicaments comprising them
IL146276A0 (en) Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
IL146372A0 (en) Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives, processes for their preparation, their use and pharmaceutical preparations comprising them
ZA986967B (en) Sulfonamide-substituted compounds processes for their preparation their use as a medicament or diagnostic and medicament comprising them
ZA9711245B (en) Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparations comprising them.
ZA986340B (en) Medicaments comprising polyhydroxyalkylpyrazine derivatives novel polyhydrosyalkylpyrazine derivatives and their preparation